| Stereochemistry | ACHIRAL |
| Molecular Formula | C32H39N7O4 |
| Molecular Weight | 585.6966 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C3=CN(C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
InChI
InChIKey=AZSRSNUQCUDCGG-UHFFFAOYSA-N
InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36)
| Molecular Formula | C32H39N7O4 |
| Molecular Weight | 585.6966 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
|
|
INHIBITOR -> TARGET |
Approved for treatment of EGFR EXON 20 insertions mutations in NSLC
|
Showing 1 to 1 of 1 entries
